CAR T-Cell Responses Prove Durable in ALL, DLBCL (CME/CE)

(MedPage Today) -- Two study updates demonstrate long-term control in relapsed/refractory disease
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news